MYX 3.29% $4.40 mayne pharma group limited

Ann: 2019 Annual Report, page-19

  1. 1,839 Posts.
    lightbulb Created with Sketch. 272
    Hi Patrick. I've said it before, Feb2020 is the date, mine, and i suspect Scott's. A growth in revenue, a reduction in costs, and a return to profitability is all expected by me, and i dare say the market.

    You also too freely dismiss a number of positive tailwinds, including some of the competition shooting themselves in the foot. Tsu liked to say never interrupt your enemy when they are making a mistake, so let them continue.

    What studies were you referring to? Just curious. But i suppose that's what the share market is, buying and selling belief, analysis and sometimes luck. I'm betting on all three. No one is here with a gun to their head, are they?
 
watchlist Created with Sketch. Add MYX (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.